EUVIMEDEUVIMED entdecken
Crossref

EGCG-mediated selenium nanoparticles protect against 5-fluorouracil–induced cardiotoxicity via Nrf2/Keap1 signaling

Khaled M Alam-ElDein, Moustafa Mahmoud Abdelaziz, Salma Sabry Elgezery, Youssef Tarek Fouad, Miriam Amir Mousa, Ahmed M Elmosilhi, Malak Mostafa Mohamed, Salma A Abdo, Mennatallah T Ali, Basmala Shaher Mohamed, Radwa A Hanafy, Alzahraa A Elhemiely und 2 weitere

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-07 · 399 (10) · 16331-16352

DOI: 10.1007/s00210-026-05413-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 11.05.2026. Verfasst von Khaled M Alam-ElDein und 13 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Biology and Biotechnology Department, School of Biotechnology, Badr University in Cairo, Badr City, Cairo, 11829, Egypt. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Catechin, Kelch-Like ECH-Associated Protein 1, Fluorouracil. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 75 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

5-Fluorouracil (5-FU) is a widely used anticancer drug; however, its clinical application is limited by severe adverse effects, particularly cardiotoxicity. This study investigated the cardioprotective potential of epigallocatechin gallat-mediated selenium nanoparticles (EGCG-SeNPs) against 5-FU-induced cardiac injury in rats and explored the underlying mechanisms, with a specific focus on comparing the efficacy of the combined therapy versus EGCG or selenium monotherapy. In silico molecular docking was performed to evaluate the interaction of EGCG with inducible nitric oxide synthase (iNOS), glutathione S-transferase (GST), and tumor necrosis factor-α (TNF-α). Thirty-five male Wistar rats were randomly assigned to five groups: control, 5-FU, Na₂SeO₃&5-FU, EGCG&5-FU, and EGCG-SeNPs&5-FU. Cardiotoxicity was induced by intraperitoneal administration of 5-FU (30 mg/kg) for five consecutive days, while treatments were administered orally for 21 days. Cardiac injury biomarkers, oxidative stress parameters, inflammatory mediators, and apoptotic markers were evaluated using biochemical assays, ELISA, qRT-PCR, immunohistochemistry for Nrf2/Keap1 signaling, and histopathological examination. 5-FU induced significant cardiotoxicity, evidenced by elevated CK-MB, LDH, and troponin levels; increased lipid peroxidation; depletion of antioxidant defenses; activation of inflammatory cytokines (TNF-α, IL-1β, and NF-kB); suppression of IL-10; and enhanced apoptosis, accompanied by myocardial histopathological damage and reduced Nrf2 immunoreactivity. Treatment with EGCG or sodium selenite attenuated these alterations, while EGCG-SeNPs exerted cardioprotective effects, restoring redox balance, suppressing inflammation and apoptosis, modulating Nrf2/Keap1 signaling, and preserving myocardial architecture. EGCG-mediated selenium nanoparticles exhibit potent cardioprotective effects through antioxidant, anti-inflammatory, and antiapoptotic mechanisms. These findings highlight the therapeutic potential of EGCG-SeNPs as a promising cardioprotective strategy during 5-FU chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2CatechinKelch-Like ECH-Associated Protein 1FluorouracilNanoparticlesAntimetabolites, AntineoplasticSeleniumHeart DiseasesAnimalsMaleRats, WistarSignal TransductionCardiotoxicityOxidative StressRatsApoptosisAntioxidants

Stichwörter der Autor:innen

5-FluorouracilCardio-oncologyCardiotoxicityEpigallocatechin gallateFluoropyrimidine toxicityNrf2/Keap1 signalingRedox signalingSelenium nanoparticles

Substanzen

NF-E2-Related Factor 2CatechinKelch-Like ECH-Associated Protein 1epigallocatechin gallateKEAP1 protein, ratNfe2l2 protein, ratFluorouracilAntimetabolites, AntineoplasticSeleniumAntioxidants

Autor:innen und Institutionen

  • Molecular Biology and Biotechnology Department, School of Biotechnology, Badr University in Cairo, Badr City, Cairo, 11829, Egypt.
  • School of Biotechnology, Badr University in Cairo, Badr City, Cairo, 11829, Egypt.
  • Department of Pharmacology, Egyptian Drug Authority (EDA)-Formerly NODCAR, Giza, 12654, Egypt.
  • Life Sciences Department, Faculty of Biotechnology, Sinai University, Kantara Branch, Ismailia, 41636, Egypt. mohamed.hassany@su.edu.eg.
  • Department of Biochemistry, Faculty of Biotechnology, Kantara Branch, Sinai University, Ismailia, 41636, Egypt.

Zitieren

APA

Alam-ElDein, K. M., Abdelaziz, M. M., Elgezery, S. S., Fouad, Y. T., Mousa, M. A., Elmosilhi, A. M., Mohamed, M. M., Abdo, S. A., Ali, M. T., Mohamed, B. S., Hanafy, R. A., Elhemiely, A. A., Gadelmawla, M. H. A., & Mahran, N. A. (2026). EGCG-mediated selenium nanoparticles protect against 5-fluorouracil–induced cardiotoxicity via Nrf2/Keap1 signaling. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(10), 16331-16352. https://doi.org/10.1007/s00210-026-05413-7

Vancouver

Alam-ElDein KM, Abdelaziz MM, Elgezery SS, Fouad YT, Mousa MA, Elmosilhi AM, et al. EGCG-mediated selenium nanoparticles protect against 5-fluorouracil–induced cardiotoxicity via Nrf2/Keap1 signaling. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(10):16331-16352. doi:10.1007/s00210-026-05413-7

BibTeX
@article{AlamElDein2026,
  author = {Alam-ElDein, Khaled M and Abdelaziz, Moustafa Mahmoud and Elgezery, Salma Sabry and Fouad, Youssef Tarek and Mousa, Miriam Amir and Elmosilhi, Ahmed M and Mohamed, Malak Mostafa and Abdo, Salma A and Ali, Mennatallah T and Mohamed, Basmala Shaher and Hanafy, Radwa A and Elhemiely, Alzahraa A and Gadelmawla, Mohamed H A and Mahran, Nievin Ahmed},
  title = {EGCG-mediated selenium nanoparticles protect against 5-fluorouracil–induced cardiotoxicity via Nrf2/Keap1 signaling},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  volume = {399},
  number = {10},
  pages = {16331--16352},
  doi = {10.1007/s00210-026-05413-7}
}
Kostenlos starten →